(192 days)
Not Found
No
The summary describes a mechanical device for airway clearance and does not mention any computational or data-driven components indicative of AI/ML.
Yes
The device is intended for "secretion clearance and lung expansion," which are therapeutic purposes. It also performs "oscillating positive expiratory pressure" which helps with these therapeutic outcomes.
No
The device is described as a "Positive Expiratory Pressure (PEP) device" for "secretion clearance and lung expansion," and it can be used with "nebulized aerosol drug delivery." Its function is therapeutic, not diagnostic.
No
The device description clearly indicates it is a physical, hand-held device used for secretion clearance and lung expansion, not a software application.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device function: The description clearly states the Aerobika* device is a "hand held secretion clearance and lung expansion device that creates vibrating positive expiratory pressure when a patient exhales through the device." It is used by the patient to assist with breathing and clearing airways.
- Lack of biological sample analysis: There is no mention of the device analyzing any biological samples from the patient.
The device is a therapeutic device used to assist with respiratory function, not a diagnostic tool that analyzes samples.
N/A
Intended Use / Indications for Use
The Aerobika* Oscillating Positive Expiratory Pressure device is intended for use as a Positive Expiratory Pressure (PEP) device. The Aerobika* Oscillating PEP device may also be used simultaneously with nebulized aerosol drug delivery. The device is intended to be used by patients capable of generating an exhalation flow of 10 lpm for 3 – 4 seconds.
Product codes
BWF
Device Description
The Aerobika* Oscillating Positive Expiratory Pressure (PEP) device is indicated as a single patient use, hand held secretion clearance and lung expansion device that creates vibrating positive expiratory pressure when a patient exhales through the device. The Aerobika* device may be used simultaneously with aerosol drug delivery from a nebulizer.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Mechanical testing was conducted to characterize the operating parameters (amplitude and frequency) of the Aerobika* device to the predicate device. The test parameters evaluated are a) oscillation frequency and b) oscillation amplitude. It was observed that the ranges of data for each parameter are similar for both devices, showing clear overlap. The mean Frequency and Amplitude values for the Aerobika* device are also within 15% of the respective mean values of the predicate device. The slightly lower minimum frequency value observed for the Aerobika* device is considered clinically insignificant in terms of therapeutic effect.
The patient contacting components of the Aerobika* oscillating positive expiratory pressure device meets the requirements of ISO 10993-1:2009, Biological evaluation of medical devices, and are classified according to the within ISO 10993-1 as follows; Category: Surface device, Contact: Mucosal membranes, Contact Duration: A - Limited Exposure (≤ 24hrs), Evaluation Testing for Biological Effect: Cytotoxicity - according to ISO 10993-5, Sensitization - according to ISO 10993-10, Irritation or Intracutaneous Reactivity according to ISO 10993-10.
Cascade impactor testing was also conducted comparing the Aerobika* oscillating positive expiratory pressure device to the Acapella using a nebulizer and three (3) different drugs. The results demonstrate that the Aerobiko* device performs comparably to the Acapella device, and does not raise any new safety or efficacy related issues.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.5690 Incentive spirometer.
(a)
Identification. An incentive spirometer is a device that indicates a patient's breathing volume or flow and that provides an incentive to the patient to improve his or her ventilation.(b)
Classification. Class II (performance standards).
0
Premarket Notification 510(k) Aerobika* Oscillating Positive Expiratory Pressure (PEP) Device
Trudell Medical International
MAY 1 6 2013
Section 5 – 510(k) Summary
Prepared: 10 May 2013
510(k) Owner
| Trudell Medical International | |
|---|---|
| 725 Third Street | |
| London, Ontario N5V 5G4 | |
| CANADA | |
| Contact Person | Darryl Fischer |
| Associate Director, Global Regulatory Affairs | |
| Phone | 1-519-455-7060 ext 2140 |
| Fax | 1-519-455-6329 |
| dfischer@trudellmed.com |
Device Name
| Proprietary | Aerobika* Oscillating Positive Expiratory Pressure (PEP)
Device |
|-----------------------|--------------------------------------------------------------------|
| Common/Classification | Spirometer, Therapeutic (Incentive) |
Product Code
Classification Regulation 868.5690
Predicate Device 510(k) Number K002768
Trade/Model Name Acapella
BWF
Manufacturer DHD Healthcare Corp.
Device Description
The Aerobika* Oscillating Positive Expiratory Pressure (PEP) device is indicated as a single patient use, hand held secretion clearance and lung expansion device that creates vibrating positive expiratory pressure when a patient exhales through the device. The Aerobika* device may be used simultaneously with aerosol drug delivery from a nebulizer.
1
Section 5 – 510(k) Summary
Intended Use
The Aerobika* Oscillating Positive Expiratory Pressure device is intended for use as a Positive Expiratory Pressure (PEP) device. The Aerobika* Oscillating PEP device may also be used simultaneously with nebulized aerosol drug delivery. The device is intended to be used by patients capable of generating an exhalation flow of 10 lpm for 3 - 4 seconds.
Technological Characteristic Comparison to Predicate Device(s)
| Common Device Characteristics | |
|---|---|
| Aerobika* PEP Device | Acapella (predicate device - K002768) PEP Device |
| • combines PEP therapy with oscillations upon exhalation | • combines PEP therapy with oscillations upon exhalation |
| • may be used with a nebulizer to deliver aerosol drug | • may be used with a nebulizer to deliver aerosol drug |
| • mechanically driven using only the patient's exhaled breath | • mechanically driven using only the patient's exhaled breath |
| • not orientation dependent | • not orientation dependent |
| • can be adjusted to increase or decrease the exhalation resistance | • can be adjusted to increase or decrease the exhalation resistance |
| • the device has a removable mouthpiece | • the device has a removable mouthpiece |
| • the device can remain in the mouth through the treatment | • the device can remain in the mouth through the treatment |
| Relevant Differences in Device Characteristics | |
| • The Aerobika* Oscillating PEP can be disassembled for cleaning | • Only the mouthpiece of the Acapella device can be disassembled for cleaning |
| • The Aerobika* Oscillating PEP may be used for patients with an exhalation flow of 10 lpm and above | Two devices are available. |
| • The green or high flow device suitable for most patients. The expiratory flow of the patient must be 15 lpm or greater | |
| • The blue or low flow device is for those patients who have low expired lung volumes / less than 15 lpm |
2
Premarket Notification 510(k) Aerobika* Oscillating Positive Expiratory Pressure (PEP) Device Trudell Medical International
Section 5 - 510(k) Summary
Non-Clinical Test Summary
.
Mechanical testing was conducted to characterize the operating parameters (amplitude and frequency) of the Aerobika* device to the predicate device.
The test parameters evaluated are a) oscillation frequency and b) oscillation amplitude. It was observed that the ranges of data for each parameter are similar for both devices, showing clear overlap. The mean Frequency and Amplitude values for the Aerobika* device are also within 15% of the respective mean values of the predicate device.
The slightly lower minimum frequency value observed for the Aerobika* device is considered clinically insignificant in terms of therapeutic effect. In addition to the fact that the predicate device has exhibited lower frequencies of 8.0 Hz in previous evaluations (Volsko et al, 2003), it is also known that other medical devices utilizing wave oscillation to aid mucocillary clearance are effective down to 3Hz (Vest device, Douglas and Bond-Kendall) and 6Hz (Quake device, Okeson and McGowen, 2007).
The patient contacting components of the Aerobika* oscillating positive expiratory pressure device meets the requirements of ISO 10993-1:2009, Biological evaluation of medical devices, and are classified according to the within ISO 10993-1 as follows;
- . Category: Surface device
- . Contact: Mucosal membranes
- Contact Duration: A - Limited Exposure (≤ 24hrs)
- Evaluation Testing for Biological Effect
- o Cytotoxicity - according to ISO 10993-5
- o Sensitization - according to ISO 10993-10
- Irritation or Intracutaneous Reactivity according to ISO 10993-10 o
Section 15 of this submission contains the information regarding the biocompatibility profile of the device under review.
Cascade impactor testing was also conducted comparing the Aerobika* oscillating positive expiratory pressure device to the Acapella using a nebulizer and three (3) different drugs. The results demonstrate that the Aerobiko* device performs comparably to the Acapella device, and does not raise any new safety or efficacy related issues.
Clinical Performance Summary
Not applicable, the determination of substantial equivalence is not based on Clinical Performance Data.
3
Premarket Notification 510(k) Aerobika* Oscillating Positive Expiratory Pressure (PEP) Device Trudell Medical International
Section 5 – 510(k) Summary
Conclusions from Testing
The Aerobika* oscillating positive expiratory pressure device has been evaluated against the currently marketed (predicate) Acapella PEP device for the determination of substantial equivalency. The Aerobika* oscillating positive expiratory pressure device and the predicate device share common indications for use, operating characteristics and usage environments. The devices are both single patient use, non-sterile and are available by prescription. The Aerobica* PEP device raises no new issues regarding safety or efficacy.
Section 5 Page 4 of 4
4
Image /page/4/Picture/0 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with its wings outstretched.
DEPARTMENT OF HEALTH & HUMAN SERVICES .
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
May 16, 2013
Mr. Darryl Fischer Associate Director, Global Regulatory Affairs Trudell Medical International 725 Third Street LONDON Ontario N5V 5G4
Re: K123400
Trade/Device Name: Aerobika* Oscillating Positive Expiratory Pressure (PEP) Device Regulation Number: 21 CFR 868.5690 Regulation Name: Incentive Spirometer Regulatory Class: II Product Code: BWF Dated: January 29, 2013 Received: April 17, 2013
Dear Mr. Fischer:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note
the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Image /page/5/Picture/8 description: The image shows the text "Kwame O. Ulmer for -S FDA". The text is arranged in three lines. The first line contains the name "Kwame O. Ulmer" followed by the word "for". The second line contains the letters "FDA" in a stylized font. The third line contains the text "-S".
Anthony D. Watson, B.S., M.S., M.B.A. Director
Division of Anesthesiology, General Hospital, Respiratory, Infection Control and
Dental Devices Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure
6
Indications for Use
510(k) Number:
Device Name: Aerobika* Oscillating Positive Expiratory Pressure (PEP) Device
Indications for Use:
The Aerobika* Oscillating Positive Expiratory Pressure device is intended for use as a Positive Expiratory Pressure (PEP) device. The Aerobika* Oscillating PEP device may also be used simultaneously with nebulized aerosol drug delivery. The device is intended to be used by patients capable of generating an exhalation flow of 10 lpm for 3 – 4 seconds.
Prescription Use: (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
CONCURRENCE OF CDRH, OFFICE OF DEVICE EVALUATION (ODE)
Paul H. Shin=S
2013.05.15(10:10:35)-04'00'
'Division Sign-Off) Juvision of Anesthesiology, General Hospital -mection Control, Dental Devices
510(k) Number: K123400
Page 1 of